thiophenes has been researched along with Huntington Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Funayama, M; Mimura, M; Mimura, Y; Oi, H; Takata, T; Takeuchi, H | 1 |
| An, P; Fu, Y; Gu, H; Guo, S; He, B; Hu, Y; Li, H; Li, Z; Lu, B; Luo, S; Pan, Y; Song, H; Sun, X; Wang, C; Wen, X; Xie, X; Zhao, Q; Zhou, Z | 1 |
| Bichell, TJ; Bowman, AB; Bradley, E; Bridges, TM; Conn, PJ; Daniels, JS; Foster, DJ; Jones, CK; Klar, R; Lindsley, CW; Moehle, MS; Niswender, CM; Pancani, T; Poslusney, M; Rook, JM; Wood, MR; Xiang, Z | 1 |
| Clemens, LE; Fallier-Becker, P; Metzger, S; Müller, AJ; Nguyen, HP; Proikas-Cezanne, T; Riess, O; Walter, C | 1 |
| Auguet, M; Chabrier, PE; Demerlé-Pallardy, C | 1 |
1 review(s) available for thiophenes and Huntington Disease
| Article | Year |
|---|---|
Nitric oxide synthases: targets for therapeutic strategies in neurological diseases.
Topics: Alzheimer Disease; Amidines; Amyotrophic Lateral Sclerosis; Animals; Benzylamines; Brain Injuries; Brain Ischemia; Enzyme Induction; Humans; Huntington Disease; Mice; Mice, Neurologic Mutants; Mice, Transgenic; Nerve Degeneration; Nerve Tissue Proteins; Nervous System Diseases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Specificity; Polymethacrylic Acids; Pyrazines; Thiophenes | 1999 |
5 other study(ies) available for thiophenes and Huntington Disease
| Article | Year |
|---|---|
Effectiveness of brexpiprazole in the treatment in a patient with Huntington's disease.
Topics: Adult; Dopamine Agonists; Humans; Huntington Disease; Male; Quinolones; Thiophenes | 2020 |
Developmental alterations in Huntington's disease neural cells and pharmacological rescue in cells and mice.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Cells, Cultured; Cognitive Dysfunction; Corpus Striatum; Epigenomics; Gene Expression; Gene Expression Profiling; Gene Knockdown Techniques; Histones; Humans; Huntingtin Protein; Huntington Disease; Induced Pluripotent Stem Cells; Isoxazoles; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neurogenesis; Neurons; Peptides; Signal Transduction; Thiophenes | 2017 |
Targeting Gpr52 lowers mutant HTT levels and rescues Huntington's disease-associated phenotypes.
Topics: Age Factors; Animals; Benzamides; Corpus Striatum; Cyclic AMP; Disease Models, Animal; Drosophila; Drosophila Proteins; Exploratory Behavior; Gait; HEK293 Cells; Humans; Huntingtin Protein; Huntington Disease; Induced Pluripotent Stem Cells; Mice; Mice, Transgenic; Mutation; Neurons; Phenotype; Quinoxalines; Receptors, G-Protein-Coupled; Thiophenes; Walking | 2018 |
Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice.
Topics: Allosteric Regulation; Animals; Brain; Fluorescence; Glutamic Acid; Huntington Disease; Immunohistochemistry; Mice; Mice, Mutant Strains; Pyridazines; Receptor, Muscarinic M4; Rotarod Performance Test; Synaptic Transmission; Thiophenes | 2015 |
Activation of AMPK-induced autophagy ameliorates Huntington disease pathology in vitro.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Biphenyl Compounds; Enzyme Activation; Gene Knock-In Techniques; HEK293 Cells; Humans; Huntington Disease; Mice; Mice, Transgenic; Pyrones; Thiophenes | 2016 |